Merck's enlicitide pill lowered LDL cholesterol by up to 60%, matching injectables like Repatha and offering an easier option ...
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback